US Patent Issued to GEORG-AUGUST-UNIVERSITAT GOTTINGEN STIFTUNG OFFENTLICHEN RECHTS, UNIVERSITATSMEDIZIN on June 2 for "Regulatable adeno-associated virus (AAV) vector" (German Inventor)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,642,869, issued on June 2, was assigned to GEORG-AUGUST-UNIVERSITAT GOTTINGEN STIFTUNG OFFENTLICHEN RECHTS, UNIVERSITATSMEDIZIN (Gottingen, Germany).

"Regulatable adeno-associated virus (AAV) vector" was invented by Sebastian Kugler (Gottingen, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to regulatable adeno-associated virus (AAV) vectors as well as to their use in gene therapy. It further relates to corresponding nucleic acid molecules, host cells, non-human transgenic animals, pharmaceutical compositions and kits."

The patent was filed on Dec. 22, 2021, under Application No. 17/559,538.

*For further informatio...